Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks

Nina Sharp, Mahya Fani, Todd J Schwedt · 2026

Read Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks by Nina Sharp, Mahya Fani, Todd J Schwedt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13396075.txt.

Introduction

Nina Sharp and co-authors tested whether tweaking the color mix of ordinary white light can ease the pain of light sensitivity during a migraine attack. In their 2026 study, 21 adults with migraine were studied while an untreated attack was under way.

Each person sat under four kinds of enriched white light, boosted toward blue, cyan, green, or red, for ten minutes each in random order, with dark breaks between. Brightness was held at 400 lux throughout. Headache strength and visual discomfort were scored before and after each spell. The setup keeps the practical feel of normal room light while testing claims that certain wavelengths soothe and others provoke.

Catalog record

CREATORNina Sharp, Mahya Fani, Todd J Schwedt
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46563
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13396075

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks Authors: Nina Sharp, Mahya Fani, Todd J Schwedt Published: 2026 ABSTRACT AbstractIntroductionPhotophobia is a common and disabling symptom among those with migraine. Studies show that short-wavelength and long-wavelength light can worsen migraine pain, while narrow-band green light may provide relief. However, monochromatic lighting is not visually pleasant and practical for daily environments. This study examined whether spectral modifications of white light influence visual discomfort and migraine headache intensity during migraine attacks.MethodsIn a randomized crossover design, 21 adults with migraine were studied during an untreated migraine attack. Participants were exposed to four spectral white light conditions (blue-, cyan-, green-, and red-enriched) at 400 lx for 10 minutes each, in randomized order, with 5 minutes of dark adaptation between conditions. Headache intensity was assessed pre- and post-exposure, visual discomfort was rated once per minute, and pupil size was measured at the end of each exposure. Data were analyzed using repeated-measures analysis of variance (ANOVA) with Bonferroni-adjusted pairwise comparisons.ResultsThere was a significant main effect of lighting condition on visual discomfort, with blue-enriched white light causing significantly greater discomfort (mean 7.58 on a 0–10 numeric rating scale, SE 0.26) compared to all other lighting conditions (p < 0.001), and green-enriched light causing the least discomfort (mean 4.78, SE 0.25), significantly less than blue- and cyan-enriched light (p < 0.001). Headache intensity increased with blue-enriched white light (mean + 1.67 on a 0–10 numeric rating scale p < 0.001) and cyan-enriched light (+ 0.95; p < 0.001). In contrast, green-enriched and red-enriched light did not increase headache intensity (green, − 0.38; p = 0.134; red, + 0.24; p = 0.521). Pupil size varied by spectrum (F(3,60) = 8.09, p < 0.001, η2 = 0.288), with greater constriction under blue and cyan light and less under green, consistent with subjective discomfort.ConclusionThe spectral composition of white light influences light sensitivity and headache intensity during migraine attacks. Findings suggest that green-enriched white light may offer a practical, non-pharmacological strategy for managing migraine symptoms in everyday environments.Keywords: Photophobia, Migraine, Lighting, Light spectrum, Visual discomfort Key Summary Points Photophobia is a highly disabling symptom for those with migraine.This study tested whether spectrally modified white light differentially affects migraine headache intensity, visual discomfort, and physiological light sensitivity during active migraine attacks.Blue- and cyan-enriched white light significantly increased visual discomfort and headache intensity, whereas green-enriched white light reduced visual discomfort and was associated with the lowest headache intensity.Spectral tuning of ambient white light may serve as a practical, non-pharmacological strategy to reduce migraine symptom burden in real-world environments.These findings support future research into environmental light optimization as an adjunctive approach to migraine management. Introduction Photophobia, defined as light-induced visual discomfort and headache exacerbation with exposure to light, is an exceedingly common symptom during migraine attacks, frequently identified as the most bothersome symptom other than headache during such attacks [1, 2]. Photophobia often persists, although more mildly, between migraine attacks [3, 4]. Light, especially bright or flickering light, is also a commonly reported migraine attack trigger and photophobia is one of the most common symptoms during the prodrome phase of a migraine attack [5, 6]. Photophobia is associated with poor sleep, greater disability, more absenteeism from work, and reduced work productivity among those with migraine [7, 8]. Despite the critical role of light in migraine, the influence of everyday indoor lighting on symptom severity remains understudied in clinical and environmental research [9, 10]. Inappropriate or insufficient daily light exposure can also disrupt circadian rhythms, regulated by the hypothalamus, itself implicated as a migraine generator, further contributing to migraine attacks [11, 12]. Many people with migraine instinctively retreat into dark environments during attacks, which may reduce overall daily light exposure and reinforce circadian disruption. In a large survey, more than 90% of individuals with migraine reported using a dark room to manage attacks, with most identifying it as a reliable pain-relief strategy [13]. However, avoiding light entirely is not an ideal strategy for preventing migraine attacks and reducing symptoms during migraine attacks. Evidence suggests that targeted light therapy, which uses the biological effects of light, may offer a promising approach for pain treatment [14, 15]. The effects of light on migraine depend strongly on its wavelength and intensity. Exposure to short-wavelength (blue) and long-wavelength (red) light has been shown to worsen headache intensity, while narrow-band green light (530 ± 10 nm) can reduce pain [16–20]. Green light activates cone-driven pathways to a lesser degree, which may explain its relatively protective effects. However, monochromatic lighting is not visually pleasant and practical for daily environments. Exposure to non-white-colored light may induce visual fatigue and reduce productivity [21, 22], whereas broad-spectrum white light provides optimal support for visual comfort and task performance [23, 24]. This highlights the need to test whether modified white-light spectra can, like the therapeutic effects of green light, reduce migraine severity while maintaining visual comfort and usability in daily environments. The purpose of the present study was to determine whether the spectral composition of polychromatic white light modulates both subjective and physiological markers of migraine during an untreated attack. Specifically, we examined the effects of four spectrally tuned white-light conditions (blue-, cyan-, green-, and red-enriched) delivered at a standardized corneal illuminance representative of typical indoor office environments, on visual discomfort, headache intensity, and pupil size. By evaluating short-term exposures (10 min per spectrum) during active migraine attacks, our aim was to test the hypothesis that spectral tuning of ambient white light can differentially influence the intensity of headache and photosensitivity, as indexed by changes in participant’s ratings of headache severity and visual discomfort and by measuring pupillary response as an objective indicator of photosensitivity [25, 26]. Importantly, this approach moves beyond monochromatic laboratory paradigms toward ecologically valid lighting conditions, thereby addressing a critical translational gap in migraine research. Demonstrating that targeted spectral modification of everyday white light can attenuate migraine-related symptoms would establish a clinically scalable, non-pharmacological strategy capable of reducing disease burden in workplaces, schools, and healthcare settings where light avoidance is neither feasible nor desirable. Methods Study Design This investigation employed a randomized, within-subject crossover design to systematically evaluate the effects of four spectrally distinct white-light conditions. The crossover framework was selected to minimize inter-individual variability in migraine phenotype and photophobia severity, thereby enhancing statistical power and mechanistic interpretability. Each participant served as their own control across conditions. Following an initial screening and eligibility assessment, participants completed a single experimental laboratory session conducted during an untreated migraine attack. “Untreated” was operationally defined as the absence of using an acute migraine medication prior to completing the light exposure tasks; rescue medication use was permitted immediately following completion of the research procedures. The laboratory session lasted approximately 70 min and was designed to capture real-time modulation of migraine symptoms under controlled photic conditions while preserving the ecological relevance of an active migraine attack state. Ethical Approval The study was approved by the Institutional Review Board (IRB) of Arizona State University (Approval No. STUDY00018233) and was conducted in accordance with the ethical standards of the Declaration of Helsinki of 1964, and its later amendments. All research participants completed an informed consent process including signing an informed consent document. The informed

Read the complete text